Boehringer Ingelheim

For Healthcare Professionals

Logout

Boehringer Ingelheim

Therapeutic Area
Therapeutic Area

At Boehringer Ingelheim we are driven by the desire to serve mankind by improving human and animal health. As a successful, family owned company we plan in generations. We work together globally and with integrity. Our Focus articulates who we are and what we strive for, how we work and what we want to achieve.

Section Overview

Therapeutic Area

Section Overview

Metabolic

Oncology

Respiratory

Inflammation
Products
Products

Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative health care products.

See all products

Products

See all products
Resources
Contact
Logout

Boehringer Ingelheim

Leave this field blank

Empagliflozin

Empagliflozin
Iinagliptin

Format

Sort by

Reset all filters

0:58

What are the major challenges today with treating kidney disease?

Watch Now Opens in new tab

02.09

VoCRM||What is the clinical relevance of broader patient population studied in EMPA-KIDNEY?

Watch Now Opens in new tab

03:04

VoCRM||How are CRM conditions linked?

Watch Now Opens in new tab

03:01

PTPHF||What are the kidney benefits that empagliflozin can offer to heart failure patients?

Watch Now Opens in new tab

03:54

PTPHF||What makes SGLT2i an ideal HF therapy?

Watch Now Opens in new tab

04:28

PTPHF||What is the role of empagliflozin in patients hospitalized for heart failure?

Watch Now Opens in new tab

Pagination

Load More

Home
Metabolic
Empagliflozin

Sitemap

Therapeutic Area

Resources

BI logo

Privacy
Terms of use
Sitemap
Contact

This website is intended for healthcare professionals in Singapore. The contents of this website are for information purposes only and are not intended to substitute for advice, treatment or recommendations of a healthcare professional. For your health concerns and other questions about symptoms, treatment or medication, consult a healthcare professional.